UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Eicosapentaenoic acid reduces membrane fluidity, inhibits cholesterol domain formation, and normalizes bilayer width in atherosclerotic-like model membranes

Biochimica et biophysica acta, 2016-12, Vol.1858 (12), p.3131-3140

2016

Volltextzugriff (PDF)

Omega-3 and omega-6 fatty acids have distinct effects on endothelial fatty acid content and nitric oxide bioavailability

Prostaglandins, leukotrienes and essential fatty acids, 2021-10, Vol.173, p.102337-102337, Article 102337

2021

Volltextzugriff (PDF)

EPA and DHA containing phospholipids have contrasting effects on membrane structure

Journal of lipid research, 2021-01, Vol.62, p.100106, Article 100106

2021

Volltextzugriff (PDF)

Eicosapentaenoic Acid Inhibits Oxidation of ApoB-containing Lipoprotein Particles of Different Size In Vitro When Administered Alone or in Combination With Atorvastatin Active Metabolite Compared With Other Triglyceride-lowering Agents

Journal of cardiovascular pharmacology, 2016-07, Vol.68 (1), p.33-40

2016

Volltextzugriff (PDF)

Eicosapentaenoic acid (EPA) reduces pulmonary endothelial dysfunction and inflammation due to changes in protein expression during exposure to particulate matter air pollution

Biomedicine & pharmacotherapy, 2023-06, Vol.162, p.114629, Article 114629

2023

Volltextzugriff (PDF)

EICOSAPENTAENOIC ACID INHIBITS HIGH DENSITY LIPOPROTEIN (HDL) OXIDATION IN A SYNERGISTIC MANNER IN COMBINATION WITH ATORVASTATIN IN VITRO

Journal of the American College of Cardiology, 2020-03, Vol.75 (11), p.2259-2259

2020

Volltextzugriff (PDF)

EICOSAPENTAENOIC ACID AND ATORVASTATIN ACTIVE METABOLITE, ALONE OR IN COMBINATION, REVERSED GLUCOSE- AND OXIDIZED LDL-INDUCED ENDOTHELIAL DYSFUNCTION MEASURED EX VIVO IN RATS

Journal of the American College of Cardiology, 2016-04, Vol.67 (13), p.2320-2320

2016

Volltextzugriff (PDF)

Omega-3 fatty acid fish oil dietary supplements contain saturated fats and oxidized lipids that may interfere with their intended biological benefits

Biochemical and biophysical research communications, 2017-01, Vol.483 (1), p.425-429

2017

Volltextzugriff (PDF)

Eicosapentaenoic acid and docosahexaenoic acid have distinct membrane locations and lipid interactions as determined by X-ray diffraction

Chemistry and physics of lipids, 2018-05, Vol.212, p.73-79

2018

Volltextzugriff (PDF)

Letter by Sherratt Regarding Article, "Effects of Randomized Treatment With Icosapent Ethyl and a Mineral Oil Comparator on Interleukin-1β, Interleukin-6, C-Reactive Protein, Oxidized Low-Density Lipoprotein Cholesterol, Homocysteine, Lipoprotein(a), and Lipoprotein-Associated Phospholipase A2: A REDUCE-IT Biomarker Substudy"

Circulation (New York, N.Y.), 2022-11, Vol.146 (20), p.e282-e283

Sherratt, Samuel C R

2022

Volltextzugriff (PDF)

Eicosapentaenoic acid (EPA) has optimal chain length and degree of unsaturation to inhibit oxidation of small dense LDL and membrane cholesterol domains as compared to related fatty acids in vitro

Biochimica et biophysica acta. Biomembranes, 2020-07, Vol.1862 (7), p.183254-183254, Article 183254

2020

Volltextzugriff (PDF)

EICOSAPENTAENOIC ACID INHIBITS OXIDATION OF VERY LARGE DENSITY LIPOPROTEINS (VLDL) IN A DOSE-DEPENDENT MANNER OVER TIME AS COMPARED TO DOCOSAHEXAENOIC ACID IN VITRO

Journal of the American College of Cardiology, 2020-03, Vol.75 (11), p.2238-2238

2020

Volltextzugriff (PDF)

Eicosapentaenoic acid inhibits oxidation of high density lipoprotein particles in a manner distinct from docosahexaenoic acid

Biochemical and biophysical research communications, 2018-02, Vol.496 (2), p.335-338

2018

Volltextzugriff (PDF)

Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues

Current atherosclerosis reports, 2023-01, Vol.25 (1), p.1-17

2023

Volltextzugriff (PDF)

Are dietary fish oil supplements appropriate for dyslipidemia management? A review of the evidence

Current opinion in lipidology, 2020-04, Vol.31 (2), p.94-100

2020

Volltextzugriff (PDF)

Eicosapentaenoic Acid (EPA) has High Affinity for Cardiac Phospholipid Membranes Compared to other Triglyceride-Lowering Agents

Metabolism, clinical and experimental, 2020-03, Vol.104, p.154115, Article 154115

2020

Volltextzugriff (PDF)

EICOSAPENTAENOIC ACID INHIBITS MEMBRANE LIPID OXIDATION IN A CONCENTRATION-DEPENDENT MANNER AT PHARMACOLOGIC DOSES IN VITRO

Journal of the American College of Cardiology, 2019-03, Vol.73 (9), p.2075-2075

2019

Volltextzugriff (PDF)

Eicosapentaenoic acid improves endothelial function and nitric oxide bioavailability in a manner that is enhanced in combination with a statin

Biomedicine & pharmacotherapy, 2018-07, Vol.103, p.1231-1237

2018

Volltextzugriff (PDF)

A biological rationale for the disparate effects of omega-3 fatty acids on cardiovascular disease outcomes

Prostaglandins, leukotrienes and essential fatty acids, 2022-07, Vol.182, p.102450, Article 102450

2022

Volltextzugriff (PDF)

Omega-3-fatty acids: Do they prevent cardiovascular disease?

Baillière's best practice & research. Clinical endocrinology & metabolism, 2023-05, Vol.37 (3), p.101681, Article 101681

2023

Volltextzugriff (PDF)

Rationale for different formulations of omega-3 fatty acids leading to differences in residual cardiovascular risk reduction

Metabolism, clinical and experimental, 2022-05, Vol.130, p.155161-155161, Article 155161

2022

Volltextzugriff (PDF)

Eicosapentaenoic Acid Reduced Expression of Inflammatory Proteins in Vascular Endothelial Cells during Cytokine Treatment in Vitro

Metabolism, clinical and experimental, 2021-03, Vol.116, p.154556, Article 154556

2021

Volltextzugriff (PDF)

Multi-scale analysis of habitat fragmentation on small-mammal abundance and tick-borne pathogen infection prevalence in Essex County, MA

PloS one, 2022-06, Vol.17 (6), p.e0269768-e0269768

2022

Volltextzugriff (PDF)

PLATELET ENDOTHELIAL CELL ADHESION MOLECULE-1 (PECAM-1) AND NITROXIDATIVE STRESS REDUCED BY EICOSAPENTAENOIC ACID (EPA) DURING CYTOKINE EXPOSURE IN ENDOTHELIAL CELLS

Journal of the American College of Cardiology, 2021-05, Vol.77 (18), p.1831-1831

2021

Volltextzugriff (PDF)

EICOSAPENTAENOIC ACID (EPA) INCREASES HEME OXYGENASE-1 EXPRESSION IN ENDOTHELIAL CELLS UNDER CONDITIONS OF INFLAMMATION UNLIKE DOCOSAHEXAENOIC ACID (DHA)

Journal of the American College of Cardiology, 2021-05, Vol.77 (18), p.1829-1829

2021

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(32)

Sprache

Englisch
(32)
Japanisch
(2)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Eicosapentaenoic acid reduces membrane fluidity, inhibits cholesterol domain formation, and normalizes bilayer width in atherosclerotic-like model membranes

Omega-3 and omega-6 fatty acids have distinct effects on endothelial fatty acid content and nitric oxide bioavailability

EPA and DHA containing phospholipids have contrasting effects on membrane structure

Eicosapentaenoic Acid Inhibits Oxidation of ApoB-containing Lipoprotein Particles of Different Size In Vitro When Administered Alone or in Combination With Atorvastatin Active Metabolite Compared With Other Triglyceride-lowering Agents

Eicosapentaenoic acid (EPA) reduces pulmonary endothelial dysfunction and inflammation due to changes in protein expression during exposure to particulate matter air pollution

EICOSAPENTAENOIC ACID INHIBITS HIGH DENSITY LIPOPROTEIN (HDL) OXIDATION IN A SYNERGISTIC MANNER IN COMBINATION WITH ATORVASTATIN IN VITRO

EICOSAPENTAENOIC ACID AND ATORVASTATIN ACTIVE METABOLITE, ALONE OR IN COMBINATION, REVERSED GLUCOSE- AND OXIDIZED LDL-INDUCED ENDOTHELIAL DYSFUNCTION MEASURED EX VIVO IN RATS

Omega-3 fatty acid fish oil dietary supplements contain saturated fats and oxidized lipids that may interfere with their intended biological benefits

Eicosapentaenoic acid and docosahexaenoic acid have distinct membrane locations and lipid interactions as determined by X-ray diffraction

Eicosapentaenoic acid (EPA) has optimal chain length and degree of unsaturation to inhibit oxidation of small dense LDL and membrane cholesterol domains as compared to related fatty acids in vitro

EICOSAPENTAENOIC ACID INHIBITS OXIDATION OF VERY LARGE DENSITY LIPOPROTEINS (VLDL) IN A DOSE-DEPENDENT MANNER OVER TIME AS COMPARED TO DOCOSAHEXAENOIC ACID IN VITRO

Eicosapentaenoic acid inhibits oxidation of high density lipoprotein particles in a manner distinct from docosahexaenoic acid

Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues

Are dietary fish oil supplements appropriate for dyslipidemia management? A review of the evidence

Eicosapentaenoic Acid (EPA) has High Affinity for Cardiac Phospholipid Membranes Compared to other Triglyceride-Lowering Agents

EICOSAPENTAENOIC ACID INHIBITS MEMBRANE LIPID OXIDATION IN A CONCENTRATION-DEPENDENT MANNER AT PHARMACOLOGIC DOSES IN VITRO

Eicosapentaenoic acid improves endothelial function and nitric oxide bioavailability in a manner that is enhanced in combination with a statin

A biological rationale for the disparate effects of omega-3 fatty acids on cardiovascular disease outcomes

Omega-3-fatty acids: Do they prevent cardiovascular disease?

Rationale for different formulations of omega-3 fatty acids leading to differences in residual cardiovascular risk reduction

Eicosapentaenoic Acid Reduced Expression of Inflammatory Proteins in Vascular Endothelial Cells during Cytokine Treatment in Vitro

Multi-scale analysis of habitat fragmentation on small-mammal abundance and tick-borne pathogen infection prevalence in Essex County, MA

PLATELET ENDOTHELIAL CELL ADHESION MOLECULE-1 (PECAM-1) AND NITROXIDATIVE STRESS REDUCED BY EICOSAPENTAENOIC ACID (EPA) DURING CYTOKINE EXPOSURE IN ENDOTHELIAL CELLS

EICOSAPENTAENOIC ACID (EPA) INCREASES HEME OXYGENASE-1 EXPRESSION IN ENDOTHELIAL CELLS UNDER CONDITIONS OF INFLAMMATION UNLIKE DOCOSAHEXAENOIC ACID (DHA)

Suchergebnisse filtern